[CEO 메세지] 카티스템, 일본임상 3상 승인 – 메디포스트

.rs-layer.slidelink a div{--wpr-bg-eeba10a3-37c8-456d-a51d-08ce57ad8896: url('https://www.medi-post.co.kr/wp-content/plugins/revslider/sr6/assets/assets/coloredbg.png');}.rs-layer.slidelink a span{--wpr-bg-5972573d-3a87-4189-ae21-0711d9d8479e: url('https://www.medi-post.co.kr/wp-content/plugins/revslider/sr6/assets/assets/coloredbg.png');}.rll-youtube-player .play{--wpr-bg-d938a5bb-b756-40df-b0ac-42c03bc13c3b: url('https://www.medi-post.co.kr/wp-content/plugins/wp-rocket/assets/img/youtube.png');}